Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

Spacer devices for inhaled therapy: why use them, and how?

Vincken W, Levy ML, Scullion J, Usmani OS, Dekhuijzen PNR, Corrigan CJ.

ERJ Open Res. 2018 Jun 18;4(2). pii: 00065-2018. doi: 10.1183/23120541.00065-2018. eCollection 2018 Apr. Review.

2.

Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial.

Duenk RG, Verhagen C, Bronkhorst EM, van Mierlo P, Broeders M, Collard SM, Dekhuijzen P, Vissers K, Heijdra Y, Engels Y.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 28;12:2795-2806. doi: 10.2147/COPD.S141974. eCollection 2017.

3.

Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.

Duenk RG, Verhagen C, Bronkhorst EM, Djamin RS, Bosman GJ, Lammers E, Dekhuijzen P, Vissers K, Engels Y, Heijdra Y.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 20;12:2121-2128. doi: 10.2147/COPD.S140037. eCollection 2017.

4.

Assessment of Burden of COPD tool: evidence not perception.

Slok AHM, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MPMH, Kerstjens HAM, van der Molen T, Asijee GM, Dekhuijzen PNR, Holverda S, Salomé PL, Goossens LMA, Twellaar M, In 't Veen JCCM, van Schayck OCP.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700756. doi: 10.1183/13993003.00756-2017. Print 2017 Jul. No abstract available.

5.

Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®.

Lewis A, Torvinen S, Dekhuijzen PNR, Chrystyn H, Melani A, Zöllner Y, Kolbe K, Watson AT, Blackney M, Plich A.

Respir Med. 2017 Aug;129:179-188. doi: 10.1016/j.rmed.2017.06.018. Epub 2017 Jun 27.

6.

Maximal bronchodilation: a therapeutic target in COPD?

Agustí A, Dekhuijzen PR.

Lancet Respir Med. 2017 Jul;5(7):540-542. doi: 10.1016/S2213-2600(17)30211-4. No abstract available.

PMID:
28664854
7.

Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy.

van Boven JFM, Lavorini F, Dekhuijzen PNR, Blasi F, Price DB, Viegi G.

Eur Respir J. 2017 May 19;49(5). pii: 1700076. doi: 10.1183/13993003.00076-2017. Print 2017 May. No abstract available.

8.

Inhaler technique mastery and maintenance in healthcare professionals trained on different devices.

Bosnic-Anticevich S, Callan C, Chrystyn H, Lavorini F, Nikolaou V, Kritikos V, Dekhuijzen PNR, Roche N, Bjermer L, Rand C, Zwar N, Price DB.

J Asthma. 2018 Jan;55(1):79-88. doi: 10.1080/02770903.2017.1310227. Epub 2017 Apr 28.

PMID:
28332886
9.

Adaptation of a difficult-to-manage asthma programme for implementation in the Dutch context: a modified e-Delphi.

Honkoop PJ, Pinnock H, Kievits-Smeets RM, Sterk PJ, Dekhuijzen PN, In 't Veen JC.

NPJ Prim Care Respir Med. 2017 Feb 9;27:16086. doi: 10.1038/npjpcrm.2016.86.

10.

The view of pulmonologists on palliative care for patients with COPD: a survey study.

Duenk RG, Verhagen C, Dekhuijzen P, Vissers K, Engels Y, Heijdra Y.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:299-311. doi: 10.2147/COPD.S121294. eCollection 2017.

11.

'To use or not to use': a qualitative study to evaluate experiences of healthcare providers and patients with the assessment of burden of COPD (ABC) tool.

Slok AH, Twellaar M, Jutbo L, Kotz D, Chavannes NH, Holverda S, Salomé PL, Dekhuijzen PN, Rutten-van Mölken MP, Schuiten D, In 't Veen JC, van Schayck OC.

NPJ Prim Care Respir Med. 2016 Nov 17;26:16074. doi: 10.1038/npjpcrm.2016.74.

12.

Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device.

Dekhuijzen PNR, Batsiou M, Bjermer L, Bosnic-Anticevich S, Chrystyn H, Papi A, Rodríguez-Roisin R, Fletcher M, Wood L, Cifra A, Soriano JB, Price DB.

Respir Med. 2016 Nov;120:54-63. doi: 10.1016/j.rmed.2016.09.015. Epub 2016 Sep 22.

13.

[Effectiveness of the Assessment of Burden of COPD tool: a cluster-randomised controlled trial].

van Schayck OC, Slok AH, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MP, Kerstjens HA, van der Molen T, Asijee GM, Dekhuijzen PN, Holverda S, Salomé PL, Goossens LM, Twellaar M, In 't Veen JC.

Ned Tijdschr Geneeskd. 2016;160:D955. Dutch.

PMID:
27805538
14.

Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study.

van Helvoort HA, Willems LM, Dekhuijzen PR, van Hees HW, Heijdra YF.

NPJ Prim Care Respir Med. 2016 Oct 13;26:16054. doi: 10.1038/npjpcrm.2016.54.

15.

Development of a diagnostic decision tree for obstructive pulmonary diseases based on real-life data.

Metting EI, In 't Veen JC, Dekhuijzen PN, van Heijst E, Kocks JW, Muilwijk-Kroes JB, Chavannes NH, van der Molen T.

ERJ Open Res. 2016 Jan 22;2(1). pii: 00077-2015. eCollection 2016 Jan.

16.

Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®).

Dekhuijzen PN, Lavorini F, Usmani OS.

Patient Prefer Adherence. 2016 Aug 18;10:1561-72. doi: 10.2147/PPA.S82857. eCollection 2016. Review.

17.

The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.

Lewis A, Torvinen S, Dekhuijzen PN, Chrystyn H, Watson AT, Blackney M, Plich A.

BMC Health Serv Res. 2016 Jul 12;16:251. doi: 10.1186/s12913-016-1482-7.

18.

Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care.

Slok AH, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MP, Kerstjens HA, van der Molen T, Asijee GM, Dekhuijzen PN, Holverda S, Salomé PL, Goossens LM, Twellaar M, In 't Veen JC, van Schayck OC.

BMJ Open. 2016 Jul 11;6(7):e011519. doi: 10.1136/bmjopen-2016-011519.

19.

Erratum: Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Levy ML, Dekhuijzen P, Barnes PJ, Broeders M, Corrigan CJ, Chawes BL, Corbetta L, Dubus JC, Hausen T, Lavorini F, Roche N, Sanchis J, Usmani OS, Viejo J, Vincken W, Voshaar T, Crompton GK, Pedersen S.

NPJ Prim Care Respir Med. 2016 May 26;26:16028. doi: 10.1038/npjpcrm.2016.28. eCollection 2016.

20.

Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Levy ML, Dekhuijzen PN, Barnes PJ, Broeders M, Corrigan CJ, Chawes BL, Corbetta L, Dubus JC, Hausen T, Lavorini F, Roche N, Sanchis J, Usmani OS, Viejo J, Vincken W, Voshaar T, Crompton GK, Pedersen S.

NPJ Prim Care Respir Med. 2016 Apr 21;26:16017. doi: 10.1038/npjpcrm.2016.17. Review. Erratum in: NPJ Prim Care Respir Med. 2016 May 26;26:16028.

21.

The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.

Roche N, Dekhuijzen PN.

J Aerosol Med Pulm Drug Deliv. 2016 Aug;29(4):311-27. doi: 10.1089/jamp.2015.1232. Epub 2016 Jan 29. Review.

PMID:
26824873
22.

Guidance on handheld inhalers in asthma and COPD guidelines: An update.

Dekhuijzen PN.

Respir Med. 2015 Dec;109(12):1592-3. doi: 10.1016/j.rmed.2015.10.017. Epub 2015 Nov 3. No abstract available.

23.

Persistence of impaired health status of Q fever patients 4 years after the first Dutch outbreak.

Limonard GJ, Peters JB, Besselink R, Groot CA, Dekhuijzen PN, Vercoulen JH, Nabuurs-Franssen MH.

Epidemiol Infect. 2016 Apr;144(6):1142-7. doi: 10.1017/S0950268815002216. Epub 2015 Oct 28.

PMID:
26508155
24.

Using the Lower Limit of Normal Instead of the Conventional Cutoff Values to Define Predictors of Pulmonary Function Impairment in Subjects With Chronic Heart Failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Respir Care. 2016 Feb;61(2):173-83. doi: 10.4187/respcare.04101. Epub 2015 Oct 20.

25.

Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.

Simons SO, van der Laan T, de Zwaan R, Kamst M, van Ingen J, Dekhuijzen PN, Boeree MJ, van Soolingen D.

Int J Tuberc Lung Dis. 2015 Jul;19(7):828-33. doi: 10.5588/ijtld.15.0043.

PMID:
26056110
26.

Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice.

Schellekens WJ, van Hees HW, Linkels M, Dekhuijzen PN, Scheffer GJ, van der Hoeven JG, Heunks LM.

Crit Care. 2015 Mar 2;19:69. doi: 10.1186/s13054-015-0798-8.

27.

The minimal clinically important difference of the Control of Allergic Rhinitis and Asthma Test (CARAT): cross-cultural validation and relation with pollen counts.

van der Leeuw S, van der Molen T, Dekhuijzen PN, Fonseca JA, van Gemert FA, Gerth van Wijk R, Kocks JW, Oosterom H, Riemersma RA, Tsiligianni IG, de Weger LA, Oude Elberink JN, Flokstra-de Blok BM.

NPJ Prim Care Respir Med. 2015 Jan 8;25:14107. doi: 10.1038/npjpcrm.2014.107.

28.

Incidence and Prevalence of COPD By Gold 2013 Classification in the Netherlands.

Van den Berg EJ, Overbeek JA, Penning-van Beest FJ, Khalid JM, Dekhuijzen PN, Herings R.

Value Health. 2014 Nov;17(7):A590. doi: 10.1016/j.jval.2014.08.2020. Epub 2014 Oct 26. No abstract available.

29.

Serial pulmonary function tests to diagnose COPD in chronic heart failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PR, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Transl Respir Med. 2014 Dec;2(1):12. Epub 2014 Sep 25.

30.

Impact of multiple-dose versus single-dose inhaler devices on COPD patients' persistence with long-acting β₂-agonists: a dispensing database analysis.

van Boven JF, van Raaij JJ, van der Galiën R, Postma MJ, van der Molen T, Dekhuijzen PN, Vegter S.

NPJ Prim Care Respir Med. 2014 Oct 2;24:14069. doi: 10.1038/npjpcrm.2014.69.

31.

Distress in suspected lung cancer patients following rapid and standard diagnostic programs: a prospective observational study.

Brocken P, van der Heijden EH, Oud KT, Bootsma G, Groen HJ, Donders AR, Dekhuijzen PN, Prins JB.

Psychooncology. 2015 Apr;24(4):433-41. doi: 10.1002/pon.3660. Epub 2014 Sep 9.

PMID:
25201175
32.

Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD.

Slok AH, in 't Veen JC, Chavannes NH, van der Molen T, Rutten-van Mölken MP, Kerstjens HA, Salomé PL, Holverda S, Dekhuijzen PN, Schuiten D, Asijee GM, van Schayck OC.

NPJ Prim Care Respir Med. 2014 Jul 10;24:14021. doi: 10.1038/npjpcrm.2014.21.

33.

Pulmonary function impairment in patients with chronic heart failure: lower limit of normal versus conventional cutoff values.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2014 Jul-Aug;43(4):311-6. doi: 10.1016/j.hrtlng.2014.03.011.

PMID:
24992882
34.

Burden of Exacerbations in Patients with Moderate to Very Severe COPD in the Netherlands: A Real-life Study.

Overbeek JA, Penning-van Beest FJ, Balp MM, Dekhuijzen PN, Herings RM.

COPD. 2015 Apr;12(2):132-43. doi: 10.3109/15412555.2014.898053. Epub 2014 Jun 24.

PMID:
24960237
35.

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.

Simons SO, van der Laan T, Mulder A, van Ingen J, Rigouts L, Dekhuijzen PN, Boeree MJ, van Soolingen D.

Clin Microbiol Infect. 2014 Oct;20(10):1015-20. doi: 10.1111/1469-0691.12696. Epub 2014 Jul 16.

36.

An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, Gosker HR, Gosselink R, Hayot M, Hussain SN, Janssens W, Polkey MI, Roca J, Saey D, Schols AM, Spruit MA, Steiner M, Taivassalo T, Troosters T, Vogiatzis I, Wagner PD; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD.

Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST. Review.

37.

Guidance on handheld inhalers in asthma and COPD guidelines.

Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J.

Respir Med. 2014 May;108(5):694-700. doi: 10.1016/j.rmed.2014.02.013. Epub 2014 Mar 1. Review.

38.

Methylation analysis in spontaneous sputum for lung cancer diagnosis.

Hubers AJ, van der Drift MA, Prinsen CF, Witte BI, Wang Y, Shivapurkar N, Stastny V, Bolijn AS, Hol BE, Feng Z, Dekhuijzen PN, Gazdar AF, Thunnissen E.

Lung Cancer. 2014 May;84(2):127-33. doi: 10.1016/j.lungcan.2014.01.019. Epub 2014 Jan 31.

PMID:
24598366
39.

Hypercapnia attenuates ventilator-induced diaphragm atrophy and modulates dysfunction.

Schellekens WJ, van Hees HW, Kox M, Linkels M, Acuña GL, Dekhuijzen PN, Scheffer GJ, van der Hoeven JG, Heunks LM.

Crit Care. 2014 Feb 9;18(1):R28. doi: 10.1186/cc13719.

40.

Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach.

Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, van Aalderen WM, Price D.

Respir Med. 2013 Dec;107(12):1817-21. doi: 10.1016/j.rmed.2013.09.013. Epub 2013 Sep 25. Review.

41.

Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Pulm Pharmacol Ther. 2014 Aug;28(2):158-64. doi: 10.1016/j.pupt.2013.09.002. Epub 2013 Sep 25.

PMID:
24076367
42.

Reply to letter to the Editor.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 Sep-Oct;42(5):388-9. doi: 10.1016/j.hrtlng.2013.07.003. No abstract available.

PMID:
23998386
43.

COPD in chronic heart failure: less common than previously thought?

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 Sep-Oct;42(5):365-71. doi: 10.1016/j.hrtlng.2013.07.002.

44.

Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections.

Magis-Escurra C, Alffenaar JW, Hoefnagels I, Dekhuijzen PN, Boeree MJ, van Ingen J, Aarnoutse RE.

Int J Antimicrob Agents. 2013 Sep;42(3):256-61. doi: 10.1016/j.ijantimicag.2013.05.007. Epub 2013 Jul 7.

PMID:
23837923
45.

[Medicinal intervention for COPD; even in patients with mild or moderate COPD?].

Dekhuijzen PN, van Helvoort HA, Willems LM, Heijdra YF.

Ned Tijdschr Geneeskd. 2013;157(26):A5399. Review. Dutch.

PMID:
23835231
46.

The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Respir Med. 2013 Sep;107(9):1393-9. doi: 10.1016/j.rmed.2013.05.008. Epub 2013 Jun 12.

47.

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Daza R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gómez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsåker T, Marras TK, Maugein J, Milburn HJ, Mlinkó T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Peña M, Piersimoni C, Polanová M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabó N, Thomson R, Tórtola Fernandez T, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop KL, Wagner D; Nontuberculous Mycobacteria Network European Trials Group.

Eur Respir J. 2013 Dec;42(6):1604-13. doi: 10.1183/09031936.00149212. Epub 2013 Apr 18.

48.

High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.

Brocken P, van der Heijden HF, Dekhuijzen PN, Peters-Bax L, de Geus-Oei LF.

Respiration. 2014;87(1):32-7. doi: 10.1159/000347096. Epub 2013 Apr 16.

49.

Reply to letter to the Editor.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 May-Jun;42(3):229-30. doi: 10.1016/j.hrtlng.2013.03.001. Epub 2013 Mar 22. No abstract available.

PMID:
23522807
50.

Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1.

Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF.

Respir Med. 2013 Jun;107(6):834-40. doi: 10.1016/j.rmed.2013.02.017. Epub 2013 Mar 17.

Supplemental Content

Loading ...
Support Center